Rasna Therapeutics Competitors and Similar CompaniesClear all
Rasna Therapeutics's competitors and similar companies include LadRx and Fennec Pharma.
 Rasna Therapeutics Rasna Therapeutics focusses on development therapeutics to address the high unmet need that exists for AML and other forms of leukemia. |  LadRx LadRx Corporation (formerly known as CytRx Corporation) is a biopharmaceutical company focused on discovering, developing and commercializing new therapeutics to treat patients with cancer. |  Fennec Pharma Fennec Pharmaceuticals is a biotechnology company focused on the development of Sodium Thiosulfate for the prevention of ototoxicity from cisplatin in pediatric patients. | |
Founding Date | Founding Date 2013 | Founding Date 1985 | Founding Date 1996 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations New York, US HQ Greater London, GB Doylestown, US | Locations Los Angeles, US HQ | Locations US HQ |
Employees | Employees N/A | Employees 385% decrease | Employees 433% increase |
Valuation ($) | Valuation ($) 3.1 m | Valuation ($) 901.1 k | Valuation ($) 129.4 m |
Financial | |||
Net income | Net income ($4.4m) (FY, 2023) | Net income ($1.6m) (FY, 2024) | Net income ($9.7m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
LadRx
HQ
Los Angeles, US
Employees
3
LadRx Corporation (formerly known as CytRx Corporation) is a biopharmaceutical company focused on discovering, developing and commercializing new therapeutics to treat patients with cancer.
View companyFennec Pharma
HQ
US
Employees
4↑ 33% increase
Fennec Pharmaceuticals is a biotechnology company focused on the development of Sodium Thiosulfate for the prevention of ototoxicity from cisplatin in pediatric patients.
View company